Trading Specifications
Minimum Price Fluctuation
--
Spreads as low as
--
Average Spreads
--
Minimum Lot Size
--
Commission
--
Trading Hours(GMT+2)
--
Maximum Trading Volume (lots)
--
News
Moderna stock soars on FDA booster trial plans
FDA to require new trials for COVID-19 boosters for under-65s
Novavax validates InvestingPro’s Fair Value analysis with 68% return
JPMorgan maintains Novavax stock Underweight with $7 target
Novavax secures FDA approval for COVID-19 vaccine
Novavax shares surge on FDA vaccine approval
Novavax gets FDA nod for Nuvaxovid vaccine in high-risk groups
Novavax : U.S. FDA Approves BLA for Novavax’s COVID-19 Vaccine
Novavax at BofA Securities: Strategic Growth and Partnerships
Novavax Reports First Quarter 2025 Financial Results and Operational Highlights
